176 related articles for article (PubMed ID: 30052928)
1. Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers.
Groarke JD; Galazka PZ; Cirino AL; Lakdawala NK; Thune JJ; Bundgaard H; Orav EJ; Levine RA; Ho CY
Eur Heart J Cardiovasc Imaging; 2018 Oct; 19(10):1109-1116. PubMed ID: 30052928
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy.
Tarkiainen M; Sipola P; Jalanko M; Heliö T; Laine M; Järvinen V; Häyrinen K; Lauerma K; Kuusisto J
J Cardiovasc Magn Reson; 2016 Jun; 18(1):33. PubMed ID: 27259862
[TBL] [Abstract][Full Text] [Related]
3. Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.
Lakdawala NK; Thune JJ; Colan SD; Cirino AL; Farrohi F; Rivero J; McDonough B; Sparks E; Orav EJ; Seidman JG; Seidman CE; Ho CY
Circ Cardiovasc Genet; 2012 Oct; 5(5):503-10. PubMed ID: 22949430
[TBL] [Abstract][Full Text] [Related]
4. Papillary muscle displacement causes systolic anterior motion of the mitral valve. Experimental validation and insights into the mechanism of subaortic obstruction.
Levine RA; Vlahakes GJ; Lefebvre X; Guerrero JL; Cape EG; Yoganathan AP; Weyman AE
Circulation; 1995 Feb; 91(4):1189-95. PubMed ID: 7850958
[TBL] [Abstract][Full Text] [Related]
5. Assessment of mitral valve function in children and young adults with hypertrophic cardiomyopathy using three-dimensional echocardiography.
Joseph N; Craft M; Mill L; Erickson CC; Danford DA; Kutty S; Li L
Int J Cardiol; 2021 Jun; 332():182-188. PubMed ID: 33753187
[TBL] [Abstract][Full Text] [Related]
6. Systolic anterior motion of the anterior mitral valve leaflet begins in subclinical hypertrophic cardiomyopathy.
Seitler S; De Zoysa Anthony S; Obianyo CCC; Syrris P; Patel V; Sado DM; Maestrini V; Castelletti S; Walsh S; O'Brien B; Moon JC; Captur G
Eur Heart J Cardiovasc Imaging; 2023 Dec; 25(1):86-94. PubMed ID: 37523765
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy.
Ho CY; Carlsen C; Thune JJ; Havndrup O; Bundgaard H; Farrohi F; Rivero J; Cirino AL; Andersen PS; Christiansen M; Maron BJ; Orav EJ; Køber L
Circ Cardiovasc Genet; 2009 Aug; 2(4):314-21. PubMed ID: 20031602
[TBL] [Abstract][Full Text] [Related]
8. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.
Vigneault DM; Yang E; Jensen PJ; Tee MW; Farhad H; Chu L; Noble JA; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Ho CY; Bluemke DA
Radiology; 2019 Mar; 290(3):640-648. PubMed ID: 30561279
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes.
van Velzen HG; Schinkel AFL; Menting ME; van den Bosch AE; Michels M
J Ultrasound; 2018 Sep; 21(3):217-224. PubMed ID: 29876904
[TBL] [Abstract][Full Text] [Related]
10. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ;
JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245
[TBL] [Abstract][Full Text] [Related]
11. Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes.
Kaple RK; Murphy RT; DiPaola LM; Houghtaling PL; Lever HM; Lytle BW; Blackstone EH; Smedira NG
Ann Thorac Surg; 2008 May; 85(5):1527-35, 1535.e1-2. PubMed ID: 18442532
[TBL] [Abstract][Full Text] [Related]
12. The mitral valve in hypertrophic cardiomyopathy: old versus new concepts.
Hagège AA; Bruneval P; Levine RA; Desnos M; Neamatalla H; Judge DP
J Cardiovasc Transl Res; 2011 Dec; 4(6):757-66. PubMed ID: 21909825
[TBL] [Abstract][Full Text] [Related]
13. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
[TBL] [Abstract][Full Text] [Related]
14. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
[TBL] [Abstract][Full Text] [Related]
15. Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction.
Klues HG; Roberts WC; Maron BJ
Circulation; 1991 Sep; 84(3):1188-97. PubMed ID: 1884449
[TBL] [Abstract][Full Text] [Related]
16. Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.
Ho CY; Lakdawala NK; Cirino AL; Lipshultz SE; Sparks E; Abbasi SA; Kwong RY; Antman EM; Semsarian C; González A; López B; Diez J; Orav EJ; Colan SD; Seidman CE
JACC Heart Fail; 2015 Feb; 3(2):180-8. PubMed ID: 25543971
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
18. Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.
Reant P; Captur G; Mirabel M; Nasis A; M Sado D; Maestrini V; Castelletti S; Manisty C; Herrey AS; Syrris P; Tome-Esteban M; Jenkins S; Elliott PM; McKenna WJ; Moon JC
J Cardiovasc Magn Reson; 2015 Jul; 17(1):64. PubMed ID: 26219660
[TBL] [Abstract][Full Text] [Related]
19. Trileaflet Mitral Valve with Three Papillary Muscles Associated with Hypertrophic Cardiomyopathy: A Novel Case.
Rosanio S; Simonsen CJ; Starwalt J; Keylani AM; Vitarelli A
Echocardiography; 2015 Sep; 32(9):1435-7. PubMed ID: 25809503
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers.
Negri F; Sanna GD; Di Giovanna G; Cittar M; Grilli G; De Luca A; Dal Ferro M; Baracchini N; Burelli M; Paldino A; Del Franco A; Pradella S; Todiere G; Olivotto I; Imazio M; Sinagra G; Merlo M
Circ Cardiovasc Imaging; 2024 Apr; 17(4):e016042. PubMed ID: 38563190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
